We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Globus Medical
GMED
$11B
| $2.35M | ﹤0.01% |
39,781
+39,758
| +172,861% | +$2.57M |
|
777
Deluxe
DLX
$1.19B
| $2.35M | ﹤0.01% |
147,437
-32,547
| -18% | -$490K |
|
778
Agree Realty
ADC
$9.5B
| $2.33M | ﹤0.01% |
31,879
-2,171
| -6% | -$163K |
|
779
Ituran Location and Control
ITRN
$1.08B
| $2.31M | ﹤0.01% |
59,607
+6,277
| +12% | +$226K |
|
780
Janux Therapeutics
JANX
$982M
| $2.31M | ﹤0.01% |
99,858
+39,278
| +65% | +$1.03M |
|
781
Impinj
PI
$5.25B
| $2.31M | ﹤0.01% |
20,768
-21,790
| -51% | -$2.17M |
|
782
ePlus
PLUS
$2.36B
| $2.3M | ﹤0.01% |
31,946
+266
| +0.8% | +$17.5K |
|
783
KBR
KBR
$4.74B
| $2.29M | ﹤0.01% |
47,683
+19,350
| +68% | +$1M |
|
784
Carrier Global
CARR
$52.7B
| $2.28M | ﹤0.01% |
31,194
| – | – |
|
785
GSK
GSK
$104B
| $2.27M | ﹤0.01% |
59,215
-22,643
| -28% | -$865K |
|
786
Ecopetrol
EC
$35.8B
| $2.27M | ﹤0.01% |
256,505
+72,580
| +39% | +$642K |
|
787
Q2 Holdings
QTWO
$3.95B
| $2.25M | ﹤0.01% |
24,100
+3,038
| +14% | +$256K |
|
788
nLIGHT
LASR
$4.26B
| $2.25M | ﹤0.01% |
+114,219
| New | +$1.42M |
|
789
Asbury Automotive
ABG
$3.88B
| $2.24M | ﹤0.01% |
9,375
+71
| +0.8% | +$16.2K |
|
790
NextEra Energy
NEE
$176B
| $2.23M | ﹤0.01% |
32,090
-151,999
| -83% | -$10.6M |
|
791
Kelly Services Class A
KELYA
$542M
| $2.21M | ﹤0.01% |
188,842
-25,772
| -12% | -$304K |
|
792
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
| – | – |
0
| – | – |
|
793
Madison Square Garden
MSGE
$3.63B
| $2.2M | ﹤0.01% |
55,171
+40,839
| +285% | +$1.44M |
|
794
Mission Produce
AVO
$1.11B
| $2.2M | ﹤0.01% |
187,970
+77,327
| +70% | +$838K |
|
795
Fastenal
FAST
$58.3B
| $2.2M | ﹤0.01% |
52,450
-790
| -1% | -$32K |
|
796
Red Violet
RDVT
$950M
| $2.2M | ﹤0.01% |
44,685
-22
| -0% | -$960 |
|
797
Intapp
INTA
$2.8B
| $2.19M | ﹤0.01% |
42,457
+7,588
| +22% | +$415K |
|
|
TEM
798
Tempus AI
TEM
$8.32B
| $2.19M | ﹤0.01% |
34,439
+17,219
| +100% | +$987K |
|
799
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| – | – |
0
| – | – |
|
800
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| – | – |
0
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.